These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25160651)
1. Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening. Leung KH; Liu LJ; Lin S; Lu L; Zhong HJ; Susanti D; Rao W; Wang M; Che WI; Chan DS; Leung CH; Chan PW; Ma DL Methods; 2015 Jan; 71():38-43. PubMed ID: 25160651 [TBL] [Abstract][Full Text] [Related]
2. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Liu LJ; Leung KH; Chan DS; Wang YT; Ma DL; Leung CH Cell Death Dis; 2014 Jun; 5(6):e1293. PubMed ID: 24922077 [TBL] [Abstract][Full Text] [Related]
3. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Siddiquee K; Zhang S; Guida WC; Blaskovich MA; Greedy B; Lawrence HR; Yip ML; Jove R; McLaughlin MM; Lawrence NJ; Sebti SM; Turkson J Proc Natl Acad Sci U S A; 2007 May; 104(18):7391-6. PubMed ID: 17463090 [TBL] [Abstract][Full Text] [Related]
4. Chemical probes that competitively and selectively inhibit Stat3 activation. Xu X; Kasembeli MM; Jiang X; Tweardy BJ; Tweardy DJ PLoS One; 2009; 4(3):e4783. PubMed ID: 19274102 [TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling for the identification of small-molecule inhibitors of TACE. Liu LJ; Leung KH; Lin S; Chan DS; Susanti D; Rao W; Chan PW; Ma DL; Leung CH Methods; 2015 Jan; 71():92-7. PubMed ID: 25260600 [TBL] [Abstract][Full Text] [Related]
6. Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening. Hao W; Hu Y; Niu C; Huang X; Chang CP; Gibbons J; Xu J Bioorg Med Chem Lett; 2008 Sep; 18(18):4988-92. PubMed ID: 18768317 [TBL] [Abstract][Full Text] [Related]
7. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening. Zhang M; Zhu W; Li Y Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design. Yu W; Xiao H; Lin J; Li C J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330 [TBL] [Abstract][Full Text] [Related]
9. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation. Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482 [TBL] [Abstract][Full Text] [Related]
11. Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition. Martic S; Rains MK; Haftchenary S; Shahani VM; Kraskouskaya D; Ball DP; Gunning PT; Kraatz HB Mol Biosyst; 2014 Mar; 10(3):576-80. PubMed ID: 24402062 [TBL] [Abstract][Full Text] [Related]
12. Characterization of molecular recognition of STAT3 SH2 domain inhibitors through molecular simulation. Park IH; Li C J Mol Recognit; 2011; 24(2):254-65. PubMed ID: 21360612 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors. Furtek SL; Matheson CJ; Backos DS; Reigan P Oncotarget; 2016 Nov; 7(47):77998-78008. PubMed ID: 27793003 [TBL] [Abstract][Full Text] [Related]
14. Strategies and Approaches of Targeting STAT3 for Cancer Treatment. Furtek SL; Backos DS; Matheson CJ; Reigan P ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. Coleman DR; Ren Z; Mandal PK; Cameron AG; Dyer GA; Muranjan S; Campbell M; Chen X; McMurray JS J Med Chem; 2005 Oct; 48(21):6661-70. PubMed ID: 16220982 [TBL] [Abstract][Full Text] [Related]
17. Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Vuorinen A; Schuster D Methods; 2015 Jan; 71():113-34. PubMed ID: 25461773 [TBL] [Abstract][Full Text] [Related]
18. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and Lakshmanan K; T K P; K Pai SR; Rajagopal K; Byran G J Biomol Struct Dyn; 2022; 40(21):11320-11338. PubMed ID: 34463213 [TBL] [Abstract][Full Text] [Related]
19. Novel high-throughput screening system for identifying STAT3-SH2 antagonists. Uehara Y; Mochizuki M; Matsuno K; Haino T; Asai A Biochem Biophys Res Commun; 2009 Mar; 380(3):627-31. PubMed ID: 19285012 [TBL] [Abstract][Full Text] [Related]